Search

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES OCTOBER 28, 2020 7:00 – 8:00 pm ET SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys …

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September 30, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder TARGET AUDIENCE This activity has been designed to meet …

Differing Perspectives on Multiple Sclerosis Nursing Care

October 10, 20209:00am-12:00pm ET Target Audience The target audience for this activity is nursing professionals involved in the management of patients with MS. Learning Objectives At the conclusion of this activity, learners should be better able to: Incorporate accumulated evidence, current guidelines, and emerging new clinical data into individualized education regarding DMTs for MS as …

Practical Approaches for MS Infusion Therapies

October 15, 2020 6:20 PM – 8:00 PM (PST) PROGRAM OVERVIEW Clinicians providing infusion therapy to people with multiple sclerosis (MS) need access to the most current clinical information and real-world data in this area. This virtual program will review their mechanisms of action, efficacy, and safety of currently available MS infusion therapies. It will …

Exercise and Physical Activity Recommendations for Patients with MS

Exercise and Physical Activity Recommendations for Patients with MS Thursday, September 10, 2020 4:00 – 5:00 pm (ET) Successful completion of this activity requires that participants: register for the activity; review the required CE information included in this handout; attend the program; and complete the evaluation form. To complete the program evaluation www.surveymonkey.com/r/ExerciseMS. Target Audience …

Journal Club: Monoclonal Antibody Treatment During Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Wednesday, September 16, 2020 8:00 – 9:00 pm (ET) SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE Monoclonal Antibody Treatment During Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder TARGET AUDIENCE This activity has been designed to meet the educational needs …

Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

September 11, 2020 — 2:30-3:30 PM (EDT) This program will be conducted as a virtual satellite symposium in conjunction with the 8th Joint ACTRIMS-ECTRIMS Virtual Meeting. You must be registered for MSVirtual2020 to participate. Click here to register: https://msvirtual2020.org/registration/. Overview: Neuromyelitis Optica Spectrum Disorders (NMOSD) are rare, immune-mediated diseases of the CNS typically characterized by …

Journal Club: The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis

Release Date: August 24, 2020 Valid for Credit Through: August 31, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis TARGET AUDIENCE This activity has been designed to meet the educational needs of physicians, …

Multiple Sclerosis Research to Practice I: Neuropathology and Biomarkers

LIVE ACTIVITY: September 14, 2020 1:00-2:00pm ET Multiple Sclerosis Research to Practice I: Neuropathology and Biomarkers Jointly provided by Consortium of Multiple Sclerosis Centers and PlatformQ Health Education, LLC Credit Available Physicians— maximum of 1 AMA PRA Category 1 Credit(s)™ Nurses— 1 Nursing Contact Hours Pharmacists— 1 Contact Hours (0.1 CEUs) Acknowledgment This activity is supported …

Multiple Sclerosis Research to Practice II: High-Efficacy DMTs

LIVE ACTIVITY: September 14, 2020 2:00-3:00pm ET Multiple Sclerosis Research to Practice II: High-Efficacy DMTs Jointly provided by Consortium of Multiple Sclerosis Centers and PlatformQ Health Education, LLC Credit Available Physicians— maximum of 1 AMA PRA Category 1 Credit(s)™ Nurses— 1 Nursing Contact Hours Pharmacists— 1 Contact Hours (0.1 CEUs) Acknowledgment This activity is supported by …